financial guidance Twist Bioscience Shares Fall 17 Percent as Fiscal Q2 Guidance Comes In Below Wall Street Estimates Twist provided fiscal second quarter revenue guidance of approximately $56.5 million, with $24 million in synbio revenues and $25 million in NGS revenues. Roche Diagnostics Revenues Essentially Flat in 2022 Molecular lab revenues fell 17 percent during the year, while core lab sales were up 3 percent and point-of-care revenues grew 15 percent. Thermo Fisher Scientific Clinical Research Business Delivers Strong Results in First Full Year Premium Acquired in December 2021, PPD delivered over 20 percent of Thermo Fisher's core organic revenue growth in the fourth quarter and contributed $1.90 billion in revenue. Abbott Q4 Diagnostics Revenues Fall 26 Percent on Declining COVID-19 Sales The company announced that its total revenues for the quarter declined 12 percent, while revenues for the full year rose 1 percent. Danaher Q4 Revenues Rise 3 Percent Despite Difficulties in China The firm's Life Sciences segment saw 8 percent growth year over year, while the Diagnostics sector rose 3 percent in the quarter. Jan 17, 2023 Oxford Nanopore Technologies Expects 2022 Revenue to Rise 49 Percent Jan 9, 2023 Sema4 Changes Name to GeneDx, Provides Preliminary 2022 Revenues, 2023 Guidance Nov 21, 2022 Agilent Fiscal Q4 Revenues Rise 11 Percent, Full-Year 2022 Revenues Grow 8 Percent Nov 18, 2022 Twist Bioscience Provides Update on New Factory as Fiscal Q4 Revenues Grow 51 Percent Nov 15, 2022 Ginkgo Bioworks Raises FY 2022 Guidance as Focus on Biosecurity Intensifies Nov 14, 2022 SomaLogic Scores One-Time, $21.2M Licensing Royalty in Q3, Raises FY 2022 Revenue Guidance Nov 14, 2022 Sema4 Exiting Reproductive Health Screening, Cutting 500 More Jobs in Latest Restructuring Nov 10, 2022 Olink Q3 Revenues up 59 Percent Nov 10, 2022 Cue Health Q3 Revenues Decline 69 Percent Nov 9, 2022 Natera Raises Guidance on Test Volume Growth, Notes Reimbursement Opportunities Premium Nov 8, 2022 Invitae Q3 Revenues Rise 17 Percent as Company Revises Cash Burn Guidance Nov 8, 2022 Pacific Biosciences Announces Revio Preorders as Q3 Revenues Dip 7 Percent Nov 8, 2022 23andMe Fiscal Q2 Revenues Grow 37 Percent as Firm Leans Into DTC Primary Care Strategy Nov 7, 2022 Akoya Biosciences Reports 40 Percent Revenue Jump in Q3, Raises Full Year Guidance Nov 4, 2022 Illumina Lowers FY 2022 Guidance as Q3 Revenues Rise 1 Percent Nov 4, 2022 Adaptive Bio Narrows 2022 Revenue Guidance, Outlines Financial Expectations Nov 3, 2022 Guardant Health Sees Promising Q3 Uptake of Shield CRC Screening Test Premium Nov 3, 2022 Exact Sciences Q3 Revenues Rise 15 Percent Nov 3, 2022 Bruker Posts 5 Percent Rise in Q3 Revenues Nov 2, 2022 10x Genomics Q3 Revenues Grow 5 Percent Load More Breaking News Bio-Rad Laboratories, Cytek Biosciences Partner on Flow Cytometry Reagents Tecan Inks Deals for NGS Library Prep System With Element Biosciences, Singular Genomics Genomenon, Flagship Biosciences Partner on Biomarker Discovery, Companion Dx Development Velsera to Integrate Arima Genomics Gene Fusion Test in Pierian Clinical Platform Evonetix Raises $24M in Extended Series B Funding Round The Scan Study Points to Tuberculosis Protection by Gaucher Disease Mutation A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds. SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource. Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages. UK Team Presents Genetic, Epigenetic Sequencing Method Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.